Categories
Alivus Life Sciences Limited — Board Meeting, 14-05-2026: Outcome of Board Meeting
14-05-2026 · 07:34 pm
Alivus Life Sciences' board has approved audited financial results for Q4 & FY26, reporting revenue of ₹2,551.83 Cr and profit of ₹564.48 Cr. They also proposed a final dividend of ₹5 per share, pending shareholder approval.
No comments yet. Be the first to comment!